3.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Omeros Corporation Borsa (OMER) Ultime notizie
FY2025 EPS Estimates for Omeros Cut by Cantor Fitzgerald - Defense World
Traders Purchase High Volume of Call Options on Omeros (NASDAQ:OMER) - Defense World
Omeros (OMER) Stock Rating and Price Target Maintained by D. Boral Capital | OMER Stock News - GuruFocus
Omeros Secures $22 Mln In Registered Direct Offering With Polar Asset Management - Nasdaq
Is Omeros Corporation a good long term investmentHigh-yield portfolio picks - PrintWeekIndia
Omeros stock rises after $22 million registered direct offering - Investing.com India
Omeros Stock Soars 8.91% on $22M Equity Offering - AInvest
Omeros (OMER) Conducts $22M Stock Sale Through Direct Offering | - GuruFocus
Omeros to raise $22 million in registered direct offering By Investing.com - Investing.com South Africa
Omeros to raise $22 million in registered direct offering - Investing.com India
Omeros Enters Securities Purchase Agreement with Polar - TipRanks
Omeros Corporation Announces Pricing of $22 Million Registered D - GuruFocus
Form 424B5 OMEROS CORP - StreetInsider
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering - The Joplin Globe
What analysts say about Omeros Corporation stockLightning-fast growth - Autocar Professional
Omeros Corporation Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com
What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com
Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser
How Omeros Corporation stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru
what makes omeros corporation stock price move sharplyFree Access to Community - Newser
FY2027 Earnings Forecast for Omeros Issued By HC Wainwright - Defense World
What makes Omeros Corporation stock price move sharplyWatchlist Winner Update - Newser
Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Wealth Enhancement Advisory Services LLC Takes $579,000 Position in Omeros Corporation (NASDAQ:OMER) - Defense World
Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN
Both retail investors who control a good portion of Omeros Corporation (NASDAQ:OMER) along with institutions must be dismayed after last week's 12% decrease - simplywall.st
Omeros shareholders elect directors and approve executive pay at annual meeting - Investing.com
Omeros stock maintains Buy rating at H.C. Wainwright on EU submission - Investing.com
Omeros (NASDAQ:OMER) Downgraded by Wall Street Zen to “Sell” - Defense World
Omeros' Narsoplimab: A Lifeline for TA-TMA Patients and a Regulatory Crossroads - AInvest
Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA | OMER Stock News - GuruFocus
Omeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock News - GuruFocus
Omeros Announces Webcast Details for Annual Meeting of Shareholders - FinancialContent
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):